முதலீட்டாளர் பிரிவு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from முதலீட்டாளர் பிரிவு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In முதலீட்டாளர் பிரிவு Today - Breaking & Trending Today

Glaukos Corporation : Announces First Quarter 2021 Financial Results

Glaukos Corporation , an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced. | May 5, 2021 ....

United States , Thomas Burns , Glaukos Corporation , Exchange Commission , Avedro Inc , Corneal Health , Micro Invasive Glaucoma Surgery , Annual Report , Quarterly Report , Investor Section , Regarding Use , Generally Accepted Accounting Principles , Glaukos Corporation Stock Exchange , Press Release , Oday Gkos Us3773221029 , ஒன்றுபட்டது மாநிலங்களில் , தாமஸ் தீக்காயங்கள் , பரிமாற்றம் தரகு , கார்னியல் ஆரோக்கியம் , மைக்ரோ ஆக்கிரமிப்பு கிள La கோமா அறுவை சிகிச்சை , ஆண்டு அறிக்கை , காலாண்டு அறிக்கை , முதலீட்டாளர் பிரிவு , தொடர்பாக பயன்பாடு ,

Glaukos Corporation Announces First Quarter 2021 Financial Results

Search jobs
Glaukos Corporation Announces First Quarter 2021 Financial Results
SAN CLEMENTE, Calif. (BUSINESS WIRE) Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the first quarter ended March 31, 2021. Key highlights include:
Net sales growth of 23% to $68.0 million in Q1 2021, compared to $55.3 million in Q1 2020.
Glaucoma net sales of $53.7 million and Corneal Health net sales of $14.3 million in Q1 2021.
Gross margin of approximately 76% and non-GAAP gross margin of approximately 84% in Q1 2021.
Operating expenses of $63.1 million and non-GAAP operating expenses of $61.8 million in Q1 2021. ....

United States , Chris Lewis , Thomas Burns , Corporate Strategy Development , Glaukos Corporation , Exchange Commission , Avedro Inc , Corneal Health , Micro Invasive Glaucoma Surgery , Annual Report , Quarterly Report , Investor Section , Regarding Use , Generally Accepted Accounting Principles , Investor Relations , Corporate Strategy , ஒன்றுபட்டது மாநிலங்களில் , கிறிஸ் லெவிஸ் , தாமஸ் தீக்காயங்கள் , பெருநிறுவன மூலோபாயம் வளர்ச்சி , பரிமாற்றம் தரகு , கார்னியல் ஆரோக்கியம் , மைக்ரோ ஆக்கிரமிப்பு கிள La கோமா அறுவை சிகிச்சை , ஆண்டு அறிக்கை , காலாண்டு அறிக்கை , முதலீட்டாளர் பிரிவு ,

DGAP-News: Clean Power Capital Corp.: Clean Power erhöht ihre Investition in PowerTap auf 94,5 %

DGAP-News: Clean Power Capital Corp.: Clean Power erhöht ihre Investition in PowerTap auf 94,5 %
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , British Columbia , White House , District Of Columbia , Vito Palmeri Amw , Powertap Salim Rahemtulla , Joel Dumaresq , Company Participation In Powertap Hydrogen Fueling Corp , Colvin Oil Llc , Clean Power Capital Corp , Co Public Relations , Andretti Group , Canadian Securities Exchange , Strategic Clean Power Capital Corp , A Service , Network Of Connections , Hydrogen Asa Key , Agreement The Andretti Group On Marketing , Clean Power , Power Capital Corp , Company Participation , Powertap Hydrogen Fueling Corp , Building The , Further Information , Clean Powers , Investment Has ,

Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2020 Net Sales

Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2020 Net Sales
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2020 Net Sales
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced its preliminary, unaudited net sales for the fourth quarter and full year ended December 31, 2020.
Preliminary and unaudited total net sales for the fourth quarter of 2020 are expected to be approximately $73 million, consisting of approximately $58 million in Glaucoma net sales and approximately $15 million in Corneal Health net sales.
Preliminary and unaudited total net sales for the full year of 2020 are expected to be approximately $225 million, consisting of approximately $179 million in Glaucoma net sales and approximately $46 million in Corneal Health net sales. ....

United States , Chris Lewis , Thomas Burns , Glaukos Corporation , Exchange Commission On , Investor Relations Corporate Strategy Development , Corneal Health , Micro Invasive Glaucoma Surgery , Risk Factors , Quarterly Report , Exchange Commission , Investor Section , Investor Relations , Corporate Strategy , ஒன்றுபட்டது மாநிலங்களில் , கிறிஸ் லெவிஸ் , தாமஸ் தீக்காயங்கள் , பரிமாற்றம் தரகு ஆன் , முதலீட்டாளர் உறவுகள் பெருநிறுவன மூலோபாயம் வளர்ச்சி , கார்னியல் ஆரோக்கியம் , மைக்ரோ ஆக்கிரமிப்பு கிள La கோமா அறுவை சிகிச்சை , ஆபத்து காரணிகள் , காலாண்டு அறிக்கை , பரிமாற்றம் தரகு , முதலீட்டாளர் பிரிவு , முதலீட்டாளர் உறவுகள் ,

Glaukos' iDose® TR Demonstrates Sustained IOP Reduction and Favorable Safety Profile Over 24 Months in Phase 2b Study

Press release content from Business Wire. The AP news staff was not involved in its creation. ....

United States , Hong Kong , Chris Lewis , Thomas Burns , Exchange Commission , Glaukos Corporation , Exchange Commission On , Investor Relations Corporate Strategy Development , European Union , Drug Administration , New Drug , Micro Invasive Glaucoma Surgery , Quarterly Report , Investor Section , Media Contact , Investor Relations , Corporate Strategy , Business Wire , Products And Services , Drug Approvals , Coronavirus Pandemic , Product Approvals , Product Testing , Diagnosis And Treatment , Pharmaceutical Manufacturing , Health Care Industry ,